CVRx (CVRX) Change in Accured Expenses (2020 - 2026)
CVRx's (CVRX) quarterly Change in Accured Expenses came in at -$2.9 million in Q1 2026, down 27.0% year-on-year from -$4.0 million in Q1 2025, and down 244.12% quarter-over-quarter from $2.0 million in Q4 2025.
CVRx (CVRX) Change in Accured Expenses (2020 - 2026) Analysis & Trends
CVRx's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 27.0% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 230.51% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, down 30.18% from the prior year.
- Change in Accured Expenses slipped to -$2.9 million in Q1 2026 per CVRX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.1 million in Q3 2024 and bottomed at -$2.9 million in Q1 2026.
- The 5-year median for Change in Accured Expenses is $289000.0 (2022), against an average of $126176.5.
- Biggest YoY gain for Change in Accured Expenses was 1486.11% in 2025; the steepest drop was 2691.46% in 2025.
- Year by year, Change in Accured Expenses stood at $289000.0 in 2022, then slumped by 197.58% to -$282000.0 in 2023, then soared by 303.55% to $574000.0 in 2024, then surged by 251.39% to $2.0 million in 2025, then tumbled by 244.12% to -$2.9 million in 2026.
- Per Business Quant, the three latest CVRX Change in Accured Expenses figures stand at -$2.9 million (Q1 2026), $2.0 million (Q4 2025), and $1.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 21.07 Mn |
| 10 | CVRx | 130.72 Mn | 58.42 Mn | 12.88 Mn | -2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.91 Mn |
| Mar 31, 2026 | -2.91 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 998,000.00 |
| Jun 30, 2025 | 998,000.00 |
| Mar 31, 2025 | -2.29 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | 574,000.00 |
| Dec 31, 2024 | 574,000.00 |
| Sep 30, 2024 | 2.14 Mn |
| Sep 30, 2024 | 2.14 Mn |
| Jun 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Mar 31, 2024 | -82,000.00 |
| Dec 31, 2023 | -282,000.00 |
| Dec 31, 2023 | -282,000.00 |